한국어
English
日本語
中文(简体)
Myungin Nalcalisin Tablet 50 mg (Benzbromarone)
50mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.
Benzbromarone is a compound used to treat gout by promoting uric acid excretion.
MFDS ingredient code M050819
Benzbromarone is a drug that increases uric acid excretion and is primarily used for the treatment of gout. Its purpose is to prevent excessive accumulation of uric acid in the body and alleviate symptoms of gout.
Benzbromarone inhibits the reabsorption of uric acid in the kidneys, increasing uric acid excretion in the urine. This results in lower blood levels of uric acid, preventing gout attacks and alleviating symptoms.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other uricosuric agents, benzbromarone can affect liver metabolism, so monitoring of liver function is necessary. Furthermore, it has a mechanism of action that directly promotes uric acid excretion, unlike uric acid formation inhibitors.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
